(GRFS) Grifols - Performance 11% in 12m
Compare GRFS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-62.24%
#94 in Group
Rel. Strength
68.80%
#2497 in Universe
Total Return 12m
10.96%
#42 in Group
Total Return 5y
-63.95%
#72 in Group
P/E 26.9
68th Percentile in Group
P/E Forward 11.0
44th Percentile in Group
PEG 0.23
67th Percentile in Group
FCF Yield 2.17%
83th Percentile in Group
12m Total Return: GRFS (11%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: GRFS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GRFS
Total Return (including Dividends) | GRFS | XBI | S&P 500 |
---|---|---|---|
1 Month | -7.23% | -10.94% | -6.73% |
3 Months | -3.75% | -14.92% | -11.93% |
12 Months | 10.96% | -6.46% | 7.24% |
5 Years | -63.95% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | GRFS | XBI | S&P 500 |
1 Month | -34.5% | -52.8% | -63.5% |
3 Months | -10.7% | -92.8% | -90.3% |
12 Months | 7.30% | -32.4% | 60.6% |
5 Years | -85.1% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #84 | 4.17% | -0.53% |
3 Month | #49 | 13.1% | 9.29% |
12 Month | #43 | 18.6% | 3.47% |
5 Years | #75 | -55.4% | -82.0% |
FAQs
Does GRFS Grifols outperforms the market?
Yes,
over the last 12 months GRFS made 10.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months GRFS made -3.75%, while XBI made -14.92%.
Over the last 3 months GRFS made -3.75%, while XBI made -14.92%.
Performance Comparison GRFS vs Indeces and Sectors
GRFS vs. Indices GRFS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.42% | -0.50% | -11.8% | 3.72% |
US NASDAQ 100 | QQQ | -0.06% | 0.13% | -11.9% | 3.37% |
US Dow Jones Industrial 30 | DIA | 2.45% | -0.32% | -12.4% | 6.47% |
German DAX 40 | DAX | -0.80% | -3.29% | -31.7% | -9.37% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.99% | -3.84% | -13.0% | 1.75% |
Hongkong Hang Seng | HSI | -2.25% | -3.51% | -16.3% | -5.82% |
India NIFTY 50 | INDA | -1.73% | -9.26% | -15.2% | 7.97% |
Brasil Bovespa | EWZ | -3.85% | -7.69% | -16.9% | 19.7% |
GRFS vs. Sectors GRFS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.29% | -0.38% | -20.9% | -4.11% |
Consumer Discretionary | XLY | -1.02% | -0.39% | -17.1% | -0.33% |
Consumer Staples | XLP | 0.27% | -10.2% | -19.8% | -0.37% |
Energy | XLE | 0.35% | 5.27% | -10.5% | 23.7% |
Financial | XLF | -0.28% | -2.38% | -20.7% | -6.87% |
Health Care | XLV | 2.69% | 0.53% | -9.58% | 13.4% |
Industrial | XLI | 1.02% | -1.20% | -11.6% | 6.90% |
Materials | XLB | 0.68% | -1.38% | -4.54% | 16.9% |
Real Estate | XLRE | 0.65% | -4.0% | -11.5% | -3.77% |
Technology | XLK | 0.15% | 1.77% | -5.56% | 9.80% |
Utilities | XLU | 0.53% | -7.43% | -15.4% | -10.7% |
Aerospace & Defense | XAR | 1.87% | -4.05% | -21.2% | -10.9% |
Biotech | XBI | -3.00% | 3.71% | -0.40% | 17.4% |
Homebuilder | XHB | -1.11% | 0.89% | 2.96% | 21.5% |
Retail | XRT | -1.45% | -1.84% | -8.36% | 17.3% |